1806P Final safety and efficacy data from CLEPSIDRA trial in 2L ED-SCLC
Navarro Mendivil, A.F., Gutierrez, S., Bullock, R., Buesa, C.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1751TiP - CLEPSIDRA trial: A pilot, biomarker-guided study to assess safety, tolerability, dose finding and efficacy of iadademstat in combination with platinum-etoposide in patients with relapsed, extensive-stage small cell lung cancer
Navarro Mendivil, A.F., Gutierrez, S., Maes, T., Bullock, R., Ropacki, M., Buesa, C.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
CLEPSIDRA trial: A pilot, biomarker-guided study to assess safety, tolerability, dose finding and efficacy of iadademstat in combination with platinum-etoposide in patients with relapsed, extensive-stage small cell lung cancer
Navarro Mendivil, A.F., Gutierrez, S., Maes, T., Bullock, R., Ropacki, M., Buesa, C.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1050P Sensitization to immunotherapy through manipulation of tumor transcription by lurbinectedin
Russo-Cabrera, J.S., Ponce Aix, S., Cozar, P., Luengo, A., Navarro Mendivil, A.F., Bernabe Caro, R., Olmedo Garcia, M.E., Trigo Perez, J.M., Zugazagoitia, J., Paz-Ares, L., Otano Andres, I.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1594P Cancer mortality in young population and estimated radon areas in Spain
Ferriol-Galmés, M., Laguna Montes, J.C., Auclin, E., Garcia De Herreros, M., Muñoz i Carrillo, F.J., Gorría Puga, T., Bernabeu Aracil, M.B., Jiménez, M., Bedmar, A., García Pardo de Santayana, M., Martinez, D., Navarro Mendivil, A.F., Reguart Aransay, N., Alcolea, L., Clua, A., Castellano, G., Teixido, C., López Castro, R., Barlet-Ros, P., Mezquita, L.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1813TiP Debio 0123, a highly selective WEE1 inhibitor, combined with carboplatin (CP) and etoposide (ETOP) in patients (pts) with small cell lung cancer (SCLC) that progressed after platinum-based therapy: A phase I dose escalation and expansion study
Gambardella, V., Navarro Mendivil, A.F., Lopez-Picazo Gonzalez, J.M., Jain, P., Fernandez-Hinojal, G., De Miguel, M., Zugazagoitia, J., Gadgeel, S., Bhatti, S.A., Vilalta, A., Castanon Alvarez, E., Simoes da Rocha, P.F., Micallef, S., Frederiksen Franzen, R., Piggott, L., Bellon, A., Rodrigo Imedio, E., Paz-Ares, L.G.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1786O BMS-986012 (anti-fucosyl-monosialoganglioside-1 [fuc-GM1]) with carboplatin + etoposide + nivolumab (CE/NIVO) as first-line (1L) therapy in extensive-stage small cell lung cancer (ES-SCLC): Interim analysis (IA) of a randomized phase II study
Kalinka, E., Bahce, I., Navarro Mendivil, A.F., Ready, N., Chu, Q.S-C., Sugawara, S., Sibille, A., Provencio Pulla, M., Johnson, M.L., Hiltermann, J.T.J.N., Ciuleanu, T-E., Dziadziuszko, R., Santo, A., Zhang, Y., Liu, Y., Sarmiento, R., Tannenbaum-Dvir, S., Ojalvo, L., Wu, J., O'Byrne, K.J.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1282P Activity of brigatinib based on genomic alterations detected on ctDNA at baseline and at progression in ALK inhibitor-naïve advanced ALK+ NSCLC from the ALTA-1L trial
Mezquita, L., Laguna Montes, J.C., Ferriol-Galmés, M., Albarran Artahona, V.M., García Pardo de Santayana, M., Gorría Puga, T., Crous Bruñol, C., Jiménez, M., Bernabeu Aracil, M.B., Navarro Mendivil, A.F., Reguart Aransay, N., Arcocha, A., Teixido, C., Dingemans, A-M.C., Auclin, E.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
LBA81 Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial
Senan, S., Spigel, D.R., Cho, B.C., Laktionov, K., Zenke, Y., Lee, K.H., Wang, Q., Navarro Mendivil, A.F., Buchmeier, E.L., Sezgin Goksu, S., Badzio, A., Shi, A., Daniel, D.B., Zemanova, M., Iyengar, P., Paz-Ares, L.G., Szadkowski, L., Chugh, P., Lai, W.C.V., Cheng, Y.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1790P Phase II data of lurbinectedin (LUR) and irinotecan (IRI) in relapsed small cell lung cancer (SCLC) patients (pts) with chemotherapy-free interval (CTFI)>30 days (d)
Zugazagoitia, J., Falcon Gonzalez, A., Navarro Mendivil, A.F., Sanchez Gastaldo, A., Simoes da Rocha, P.F., Cote, G.M., Bockorny, B., Molina Cerrillo, J., Artal, A., Baena Espinar, J., Gil Torralvo, A., Ponce Aix, S., Bote De Cabo, H., Martinez Perez, J., Martínez, S., López-Vilariño, J.A., Kahatt, C., Gómez, J., Paz-Ares, L.G.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1637P Impact of immune-related adverse events (irAEs) and survival (OS) in a cohort of MPM patients (p) treated with immunotherapy (IT)
Cedres Perez, S.M., Valdivia, A., Assaf, J.D., Iranzo Gomez, P., Callejo, A., Pardo Aranda, N., Navarro Mendivil, A.F., Martinez-Marti, A., Molina, G., Navarro, V., Gonzalo, J., Soleda, M., Frigola, J., Carbonell, C., Amat, R., Dienstmann, R., Felip, E.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1989MO Lurbinectedin (LUR) in combination with pembrolizumab (PBL) in relapsed small cell lung cancer (SCLC): The phase I/II LUPER study
Blanco, A. Calles, Mendivil, A.F. Navarro, Doger de Spéville, B., Colomé, E. Álvarez, De Miguel Luken, M.J., Alvarez, R.M., Garcia, V. Moreno, J. ramon, Valles, M. Arregui, Corral de la Fuente, E., Alcalá, D., Fernández, M., Morató, J. Rodríguez, Calvo, E., Sanchez, R. Palmero, Jové, M., Felip, E.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
2193P Real-world evidence of the impact of immunotherapy (IT) on overall survival (OS) of patients (p) with malignant pleural mesothelioma (MPM) adjusted for tumor histology
Perez, S.M. Cedres, Valdivia, A.A., Pastrana, J.D. Assaf, Gomez, P. Iranzo, Perez, A. Callejo, Aranda, N. Pardo, Mendivil, A.F. Navarro, Martinez-Marti, A., Priano, I., Hermida, J.M. Ucha, Garcia-Galea, E., Gonzalo, J., Caro, R., Carbonell, C., Amat, R., Dienstmann, R., Felip, E.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
161O RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC)
Rudin, C.M., Dowlati, A., Chen, Y., Mendivil, A.F. Navarro, Yang, J.C-H., Stojanovic, G., Rich, P., Andric, Z.G., Wu, Y-L., Chen, H., Zhang, L., Yeung, S., Benzaghou, F.M., Paz-Ares, L., Bunn, P.A.
Published in Journal of thoracic oncology (01.04.2023)
Published in Journal of thoracic oncology (01.04.2023)
Get full text
Journal Article
166P Impact of immunotherapy (IT) on overall survival (OS) of patients with malignant pleural mesothelioma (MPM) adjusted for tumor histology
Perez, S.M. Cedres, Valdivia, A.A., Pastrana, J.D. Assaf, Gomez, P. Iranzo, Aranda, N. Pardo, Mendivil, A.F. Navarro, Martinez-Marti, A., Prina, M. Meazza, Garcia-Galea, E., Gonzalo, J., Dienstmann, R., Felip, E.
Published in ESMO open (01.03.2024)
Published in ESMO open (01.03.2024)
Get full text
Journal Article